ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
소변 pH 조절제 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 5.8%의 CAGR로 40억 달러에 달할 것으로 예상됩니다. 예측 기간 동안 암 발생률 증가, 신흥 시장 확대, 요로 감염증의 유행 증가, 예방 의료에 대한 관심 증가, 영양 보충제에 대한 수요 증가 등이 성장 요인으로 작용할 것으로 예상됩니다. 이 기간 동안 예상되는 주요 동향으로는 기술 발전, 비침습적 모니터링 기술, 맞춤형 의료에 대한 접근, 지속적인 기술 발전, 지속적인 제품 혁신 등이 있습니다.
신부전증의 유병률 증가는 가까운 장래에 소변 pH 조절제 시장의 확대를 촉진할 것으로 예상됩니다. 신부전은 신장이 노폐물을 걸러내고 체액 균형을 맞추고 전해질을 조절하는 능력을 상실하여 체내에 독소가 축적되어 발생합니다. 이러한 신부전의 증가는 주로 당뇨병 유병률의 증가로 인한 것으로, 당뇨병은 시간이 지남에 따라 신장 여과에 손상을 입혀 만성 신장 질환과 최종 신부전을 유발합니다. 신부전이 보편화됨에 따라 소변 pH 조절제에 대한 수요가 증가합니다. 이러한 제품은 산염기 불균형을 관리하고 신장 결석 형성을 예방하며 신장 기능 저하로 인한 합병증을 완화하는 데 도움이 되기 때문입니다. 예를 들어, 자선단체 Kidney Research UK는 2023년 6월 영국 인구의 10% 이상인 719만 명이 만성 신장 질환을 앓고 있다고 보고했습니다. 이 수치는 2033년까지 761만 명으로 증가할 것으로 예상됩니다. 결과적으로 신부전 유병률의 증가는 소변 pH 조절제 시장의 성장에 박차를 가하고 있습니다.
예방적 헬스케어에 대한 인식이 높아지면서 소변 pH 조절제 시장의 성장을 촉진할 것으로 예상됩니다. 예방 건강관리는 질병이 발생한 후 치료하는 것이 아니라 질병을 예방하기 위한 조치를 취하는 데 중점을 두고 있습니다. 만성질환을 예방하고 미래의 의료비 지출을 줄이기 위한 조기 건강관리의 중요성에 대한 인식이 높아짐에 따라 예방적 건강관리에 대한 지지가 증가하고 있습니다. 이러한 예방으로의 전환은 소변 pH 조절제에 대한 수요를 견인하고 있습니다. 요산 조절제는 요로 건강 상태를 조기에 관리할 수 있도록 도와주기 때문입니다. 소변의 pH를 균형 있게 유지함으로써 감염과 신장 결석의 위험을 줄일 수 있습니다. 예를 들어, 2024년 7월 영국 국민보건서비스(NHS)의 발표에 따르면 2024년 5월까지 노인요양시설 입소자의 51.8%가 봄철 예방접종을 받았으며, 2024년 6월까지 이 수치는 63.3%로 상승하여 11.5%의 증가를 보였다고 합니다. 그 결과, 예방적 헬스케어에 대한 관심이 높아지면서 소변 pH 조절제 시장의 성장에 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 소변 pH 조절제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 소변 pH 조절제 시장 : 성장률 분석
세계의 소변 pH 조절제 시장 실적 : 규모와 성장, 2019-2024
세계의 소변 pH 조절제 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 소변 pH 조절제 전체 시장(TAM)
제6장 시장 세분화
세계의 소변 pH 조절제 시장 약물에 의한 실적과 예측, 2019-2024, 2024-2029F, 2034F
산성 인산칼륨
중탄산 나트륨
구연산 나트륨
구연산 칼륨
세계의 소변 pH 조절제 시장 투여량별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
주사
태블릿
솔루션
분말
기타 투여량
세계의 소변 pH 조절제 시장 : 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
아르카로시스
알킬화제방광염
마음 정지
위식도역류질환
당뇨병성 케톤산증
고칼륨혈증
저나트륨혈증
소화불량
대사성 아시드시스
기타 적응증
세계의 소변 pH 조절제 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
온라인 소매
약국
슈퍼마켓
건강식품점
세계의 소변 pH 조절제 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
클리닉
홈케어
세계의 소변 pH 조절제 시장, 인산칼륨 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
인산 이수소칼륨
인산 이칼륨
복합 제제
세계의 소변 pH 조절제 시장, 중탄산나트륨 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구 중탄산나트륨자물쇠
정맥내 중탄산나트륨 주사액
발포성 중탄산나트륨 분말
세계의 소변 pH 조절제 시장 구연산 나트륨 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
구연산 나트륨 이수화물
무수 구연산 나트륨
구연산 나트륨 경구액
세계의 소변 pH 조절제 시장 구연산 칼륨 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
구연산 칼륨 서방정
구연산 칼륨 경구액
기타 알칼리화제와의 병용요법
제7장 지역별·국가별 분석
세계의 소변 pH 조절제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 소변 pH 조절제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
소변 pH 조절제 시장 : 경쟁 구도
소변 pH 조절제 시장 : 기업 개요
Cargill Incorporated Overview, Products and Services, Strategy and Financial Analysis
Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
Virbac Overview, Products and Services, Strategy and Financial Analysis
Vetoquinol Overview, Products and Services, Strategy and Financial Analysis
Otto Chemie Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Ashish Life Science
Vitalac
Apex Laboratories
Neo Kumfurt Solutions Pvt. Ltd.
Millpledge Ltd.
Vizag Chemical
Swiss Chemie
Ennore India Chemicals
East India Chemicals International
RX Chemical
Aptus
Rishi Chemical
Tricon Biochem Corporation
Orion Pharma Animal Health
Beach Pharmaceuticals
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
소변 pH 조절제 시장 2029 : 새로운 기회를 제공하는 국가
소변 pH 조절제 시장 2029 : 새로운 기회를 제공하는 부문
소변 pH 조절제 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Urinary pH modifiers are medications that help regulate the acidity or alkalinity of urine. They are commonly used to treat conditions such as urinary tract infections, kidney stones, and certain metabolic imbalances. By adjusting urinary pH, these medications can improve drug solubility, promote excretion, and reduce the risk of crystal or stone formation.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main drugs used as urinary pH modifiers include potassium acid phosphate, sodium bicarbonate, sodium citrate, and potassium citrate. Potassium acid phosphate is a mineral supplement that acidifies urine, supports kidney function, and helps prevent kidney stones by maintaining phosphate and electrolyte balance. It is available in various dosage forms, including injection, tablets, solutions, powder, and others. It is used to treat conditions such as alkalosis, alkylating agent cystitis, asystole, gastroesophageal reflux disease, diabetic ketoacidosis, hyperkalemia, hyponatremia, indigestion, metabolic acidosis, and more. These medications are distributed through several channels, including online retail, pharmacies, supermarkets, and health food stores. They are utilized by various end-users, including hospitals, clinics, and home care settings.
The urinary pH modifier market research report is one of a series of new reports from The Business Research Company that provides urinary pH modifier market statistics, including the urinary pH modifier industry global market size, regional shares, competitors with the urinary pH modifier market share, detailed urinary pH modifier market segments, market trends, and opportunities, and any further data you may need to thrive in the urinary pH modifier industry. This urinary pH modifier market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The urinary pH modifier market size has grown strongly in recent years. It will grow from$3.01 billion in 2024 to $3.19 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to the rising prevalence of renal failure, the increasing shift toward online platforms, the growing demand for pH modifier solutions, the higher incidence of urinary tract infections, and the rising prevalence of diabetes.
The urinary pH modifier market size is expected to see strong growth in the next few years. It will grow to$4.00 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The projected growth in the forecast period can be attributed to the rising frequency of cancer, the expansion of emerging markets, the increasing prevalence of urinary tract infections, a growing focus on preventive healthcare, and a higher demand for dietary supplements. Key trends expected during this period include technological advancements, non-invasive monitoring technologies, personalized medicine approaches, continued progress in technology, and ongoing product innovations.
The growing prevalence of renal failure is expected to drive the expansion of the urinary pH modifiers market in the near future. Renal failure occurs when the kidneys lose their ability to filter waste, balance fluids, and regulate electrolytes, leading to the accumulation of toxins in the body. This increase in renal failure is primarily due to the rising incidence of diabetes, which damages kidney filtration over time, resulting in chronic kidney disease and eventual renal failure. As renal failure becomes more common, the demand for urinary pH modifiers rises, as these products help manage acid-base imbalances, prevent kidney stone formation, and alleviate complications associated with impaired kidney function. For example, in June 2023, Kidney Research UK, a charitable organization, reported that 7.19 million people in the UK, or over 10% of the population, suffer from chronic kidney disease. This figure is expected to rise to 7.61 million by 2033. Consequently, the increasing prevalence of renal failure is fueling the growth of the urinary pH modifiers market.
The rising awareness of preventive healthcare is expected to drive the growth of the urinary pH modifiers market. Preventive healthcare focuses on taking measures to prevent diseases rather than treating them after they occur. As more people understand the importance of early health management to prevent chronic diseases and reduce future medical costs, preventive healthcare continues to gain traction. This shift towards prevention is driving the demand for urinary pH modifiers, as these products help manage urinary tract health early on. By balancing urine pH, they reduce the risk of infections and kidney stones. For instance, in July 2024, the National Health Service (NHS) England reported that by May 2024, 51.8% of older adult care home residents had received the spring vaccination, and by June 2024, this figure had risen to 63.3%, showing an 11.5% increase. As a result, the growing emphasis on preventive healthcare is contributing to the growth of the urinary pH modifiers market.
In September 2023, Jones-Hamilton Co., a U.S.-based manufacturer of natural acidifiers for the pet food industry, joined forces with BSM Partners to advance pet health through scientific innovation. The partnership aims to accelerate the development and use of SBSPet in the pet food industry by leveraging BSM Partners' expertise in veterinary nutrition research and strategic insights. The collaboration seeks to promote pet wellness by utilizing sodium bisulfate, improving product quality and safety, and educating the industry about the benefits of natural acidifiers in pet nutrition. BSM Partners is a U.S.-based company specializing in veterinary nutrition research.
Major players in the urinary ph modifier market are Cargill Incorporated, Intas Pharmaceuticals Ltd., Virbac, Vetoquinol, Otto Chemie Pvt. Ltd., Ashish Life Science, Vitalac, Apex Laboratories, Neo Kumfurt Solutions Pvt. Ltd., Millpledge Ltd., Vizag Chemical, Swiss Chemie, Ennore India Chemicals, East India Chemicals International, RX Chemical, Aptus, Rishi Chemical, Tricon Biochem Corporation, Orion Pharma Animal Health, and Beach Pharmaceuticals.
North America was the largest region in the urinary pH modifier market in 2024. The regions covered in urinary pH modifier report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the urinary pH modifier market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The urinary pH modifier market consists of sales of magnesium hydroxide, ammonium chloride, and acetazolamide. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Urinary pH Modifier Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on urinary ph modifier market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for urinary ph modifier ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The urinary ph modifier market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Urinary pH Modifier Market Characteristics
3. Urinary pH Modifier Market Trends And Strategies
4. Urinary pH Modifier Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Urinary pH Modifier Growth Analysis And Strategic Analysis Framework
5.1. Global Urinary pH Modifier PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Urinary pH Modifier Market Growth Rate Analysis
5.4. Global Urinary pH Modifier Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Urinary pH Modifier Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Urinary pH Modifier Total Addressable Market (TAM)
6. Urinary pH Modifier Market Segmentation
6.1. Global Urinary pH Modifier Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Potassium Acid Phosphate
Sodium Bicarbonate
Sodium Citrate
Potassium Citrate
6.2. Global Urinary pH Modifier Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injection
Tablets
Solution
Powder
Other Dosages
6.3. Global Urinary pH Modifier Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alkalosis
Alkylating Agent Cystitis
Asystole
Gastroesophageal Reflux Disease
Diabeitc Ketoacidosis
Hyperkalemia
Hyponatremia
Indigestion
Metabolic Acidosis
Other Indications
6.4. Global Urinary pH Modifier Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online Retail
Pharmacies
Supermarkets
Health Food Stores
6.5. Global Urinary pH Modifier Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Home Care
6.6. Global Urinary pH Modifier Market, Sub-Segmentation Of Potassium Acid Phosphate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monobasic Potassium Phosphate
Dibasic Potassium Phosphate
Combination Formulations
6.7. Global Urinary pH Modifier Market, Sub-Segmentation Of Sodium Bicarbonate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Sodium Bicarbonate Tablets
Intravenous Sodium Bicarbonate Injection
Effervescent Sodium Bicarbonate Powder
6.8. Global Urinary pH Modifier Market, Sub-Segmentation Of Sodium Citrate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sodium Citrate Dihydrate
Sodium Citrate Anhydrous
Sodium Citrate Oral Solution
6.9. Global Urinary pH Modifier Market, Sub-Segmentation Of Potassium Citrate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Potassium Citrate Extended-Release Tablets
Potassium Citrate Oral Solution
Combination Therapy With Other Alkalizing Agents
7. Urinary pH Modifier Market Regional And Country Analysis
7.1. Global Urinary pH Modifier Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Urinary pH Modifier Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
